Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$15.68 - $22.27 $12,089 - $17,170
-771 Reduced 67.99%
363 $6,000
Q2 2022

Aug 08, 2022

BUY
$17.44 - $23.16 $3,243 - $4,307
186 Added 19.62%
1,134 $24,000
Q1 2022

May 10, 2022

BUY
$17.03 - $22.67 $16,144 - $21,491
948 New
948 $21,000
Q4 2021

Feb 11, 2022

SELL
$15.84 - $21.88 $229,537 - $317,063
-14,491 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$16.3 - $21.14 $57,718 - $74,856
-3,541 Reduced 19.64%
14,491 $306,000
Q2 2021

Aug 09, 2021

SELL
$17.95 - $25.56 $7,862 - $11,195
-438 Reduced 2.37%
18,032 $329,000
Q1 2021

Apr 28, 2021

BUY
$20.53 - $25.22 $358,289 - $440,139
17,452 Added 1714.34%
18,470 $418,000
Q4 2020

Feb 09, 2021

SELL
$18.39 - $24.8 $349,796 - $471,720
-19,021 Reduced 94.92%
1,018 $20,000
Q3 2020

Nov 02, 2020

SELL
$20.67 - $26.94 $57,193 - $74,542
-2,767 Reduced 12.13%
20,039 $489,000
Q2 2020

Aug 11, 2020

SELL
$16.46 - $27.42 $77,707 - $129,449
-4,721 Reduced 17.15%
22,806 $542,000
Q1 2020

May 15, 2020

SELL
$14.46 - $21.8 $139,249 - $209,934
-9,630 Reduced 25.92%
27,527 $474,000
Q4 2019

Feb 13, 2020

BUY
$15.15 - $18.89 $242 - $302
16 Added 0.04%
37,157 $655,000
Q3 2019

Oct 17, 2019

BUY
$17.68 - $22.65 $83,042 - $106,387
4,697 Added 14.48%
37,141 $657,000
Q2 2019

Aug 05, 2019

BUY
$18.93 - $24.75 $150,114 - $196,267
7,930 Added 32.35%
32,444 $693,000
Q1 2019

Apr 16, 2019

BUY
$19.6 - $24.76 $60,877 - $76,904
3,106 Added 14.51%
24,514 $583,000
Q4 2018

Jan 17, 2019

SELL
$13.65 - $21.8 $28,610 - $45,692
-2,096 Reduced 8.92%
21,408 $422,000
Q3 2018

Nov 02, 2018

BUY
$15.87 - $22.4 $65,336 - $92,220
4,117 Added 21.24%
23,504 $0
Q2 2018

Jul 24, 2018

BUY
$18.56 - $22.45 $176,320 - $213,275
9,500 Added 96.09%
19,387 $0
Q1 2018

May 03, 2018

BUY
$22.15 - $31.89 $99,564 - $143,345
4,495 Added 83.36%
9,887 $218,000
Q4 2017

Feb 02, 2018

SELL
$24.23 - $30.93 $255,020 - $325,538
-10,525 Reduced 66.12%
5,392 $163,000
Q3 2017

Oct 20, 2017

BUY
$23.35 - $29.24 $371,661 - $465,413
15,917
15,917 $386,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.